FDA Inspection 1008334 — Freeman- Oak Hill Health System IRB #1
The FDA completed an inspection of Freeman- Oak Hill Health System IRB #1 on March 29, 2017 in Joplin, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Joplin, MO (United States)
Additional Details
IRB